enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. - Wikipedia

    en.wikipedia.org/wiki/Teva_Pharmaceuticals_USA...

    The case originated in the Southern District of New York, where Sandoz sued to invalidate Teva's patent on a drug for the treatment of multiple sclerosis.In the Markman hearing, Sandoz argued that a claim was fatally indefinite for failing to identify which of three possible meanings a particular claim term, related to the molecular weight of a component of the drug, should be interpreted to have.

  3. U.S. states accuse Teva, other drugmakers, of price-fixing ...

    www.aol.com/news/teva-other-drug-companies...

    U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other drug companies to inflate drug prices - sometimes by more than 1,000% - and ...

  4. The generic drug maker Teva Pharmaceuticals agreed Monday to pay $225 million to settle price-fixing charges related to sales of a major cholesterol-lowering drug. The U.S. Department of Justice ...

  5. Catalyst Pharmaceuticals Settles Patent Litigation Case With ...

    www.aol.com/catalyst-pharmaceuticals-settles...

    On Wednesday, Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) entered into a settlement agreement with Teva Pharmaceuticals Industries Ltd (NYSE:TEVA). This Agreement resolves the patent litigation ...

  6. Teva settles shareholder lawsuit over generic drug pricing ...

    www.aol.com/news/teva-settles-shareholder...

    (Reuters) -Teva Pharmaceutical Industries Ltd has agreed to pay $420 million to settle shareholder litigation alleging the company hid an anti-competitive scheme to fix the price of generic drugs.

  7. List of off-label promotion pharmaceutical settlements

    en.wikipedia.org/wiki/List_of_off-label...

    Franklin and his attorney, Thomas M. Greene, filed a lawsuit, Franklin v. Parke-Davis , under the False Claims Act in federal district court in Boston. In the first off-label promotion case ever litigated in a whistleblower suit under the False Claims Act, the settlement was announced after eight years of litigation in May 2004.

  8. EU Commission fines Teva $500 million for trying to stop ...

    www.aol.com/eu-commission-fines-teva-500...

    The European Commission said Thursday it has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its multiple sclerosis ...

  9. Teva Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Teva_Pharmaceuticals

    Teva Pharmaceutical Industries Ltd. (also known as Teva Pharmaceuticals) is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs , but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing ...